Lasa Supergenerics Q4 Results Live : loss rise by 1.92% YOY
Lasa Supergenerics Q4 Results Live : Revenue decreased by 35.41% YoY & loss increased by 1.92% YoY
Lasa Supergenerics Q4 Results Live : Lasa Supergenerics declared their Q4 results on 30 May, 2024. The topline decreased by 35.41% & the loss increased by 1.92% YoY.
As compared to the previous quarter the revenue declined by 14.42% and the loss increased by 949.25%.
The Selling, general & administrative expenses declined by 2.99% q-o-q & increased by 3.53% Y-o-Y.
The operating income was down by 847.59% q-o-q & increased by 21.86% Y-o-Y.
The EPS is ₹-1.91 for Q4 which decreased by 361.04% Y-o-Y.
Lasa Supergenerics has delivered -3.28% return in the last 1 week, -18.15% return in last 6 months and -26.09% YTD return.
Currently the Lasa Supergenerics has a market cap of ₹110.72 Cr and 52wk high/low of ₹41.2 & ₹20.6 respectively.
Lasa Supergenerics Financials
| Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 22.82 | 26.66 | -14.42% | 35.32 | -35.41% |
| Selling/ General/ Admin Expenses Total | 1.51 | 1.55 | -2.99% | 1.46 | +3.53% |
| Depreciation/ Amortization | 2.66 | 2.68 | -0.68% | 4.17 | -36.18% |
| Total Operating Expense | 38.23 | 28.29 | +35.16% | 55.05 | -30.55% |
| Operating Income | -15.42 | -1.63 | -847.59% | -19.73 | +21.86% |
| Net Income Before Taxes | -15.97 | -2.06 | -673.58% | -19.21 | +16.88% |
| Net Income | -15.3 | -1.46 | -949.25% | -15.01 | -1.92% |
| Diluted Normalized EPS | -1.91 | -0.29 | -559.73% | -0.41 | -361.04% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.